The popularity of Viagra initially drove a period of growth for pharma, but recent changes present a uncertain outlook for investors. Lower-cost competitors are reducing revenue, and ongoing patent challenges add more https://estellehjjj077192.qodsblog.com/41347418/viagra-and-big-pharma-a-risky-bet